SMi Group are pleased to present the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on the 18th-20th November 2019 in London, UK.
The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.
With this in mind, this year’s Ophthalmic Drugsconference willexplore new discoveries in the treatment of ocular rare disease; innovations in gene therapy; the challenges in drug delivery through a complex barrier; patient comfort and regulatory compliance which make up core components within the Ophthalmic Drug sphere.
NEW FOR 2019:
The brand-new Focus Day on ‘Novel Drug Delivery Through a Complex Barrier’ will bring academic perspectives on the future for ocular drug delivery and notified bodies will provide a regulatory insight into this emerging field of ophthalmic drug development.
How will you benefit?
With over 15 expert presentations, the three-day agenda offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more!
Network and learn from leading professionals such as:
CHAIRS FOR 2019:
FEATURED SPEAKERS INCLUDE:
For more information and to register, visit: www.ophthalmicdrugs.com/pnhq
Social Media Handles
Follow us on LinkedIn ‘SMi Pharma’, Twitter @SMiPharm and use #OphthalmicDrugs
Additional Contact Info:
T: +44 (0) 20 7827 6164
© 2018 PHARMA NEWS HQ, All rights reserved
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.